NCT04886232View on ClinicalTrials.gov

A Prospective, Multicenter, Randomized, Comparator-controlled, Evaluator-blinded Study to Evaluate the Safety and Effectiveness of VP1 Lido US for Volume Augmentation of the Cheek

NACompletedINTERVENTIONAL
Enrollment

202

Participants

Timeline

Start Date

May 25, 2021

Primary Completion Date

March 25, 2022

Study Completion Date

May 16, 2023

Conditions
Cheek Volume Augmentation
Interventions
DEVICE

VP1 Lido US

Hyaluronic acid dermal filler containing lidocaine

DEVICE

Restylane Lyft Lidocaine

Hyaluronic acid dermal filler containing lidocaine

Trial Locations (10)

14467

Haut- und Lasercentrum Potsdam, Merz Investigational Site #0490362, Potsdam

20146

Universität Hamburg, Merz Investigational Site #0490095, Hamburg

22609

Dermatologic Private Practice, Merz Investigational Site #0490345, Hamburg

40212

Dermatologic Private Practive, Merz Investigational Site #0490381, Düsseldorf

42287

Centroderm GmbH, Merz Investigational Site #0490367, Wuppertal

48317

Praxis für Hautkrankheiten, Merz Investigational Site #0490375, Drensteinfurt

64297

Rosenparkklinik, Merz Investigational Site #0490099, Darmstadt

65812

Hautmedizin Bad Soden, Merz Investigational Site #0490189, Bad Soden am Taunus

68161

Private Clinic, Merz Investigational Site #0490284, Mannheim

80539

Privatpraxis für Dermatologie und Ästhetik, Merz Investigational Site #0490371, München

All Listed Sponsors
lead

Merz North America, Inc.

INDUSTRY